DOXEE SPA (DOX.MI) Fundamental Analysis & Valuation

BIT:DOX • IT0005394413

Current stock price

3.72 EUR
-0.03 (-0.8%)
Last:

This DOX.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. DOX.MI Profitability Analysis

1.1 Basic Checks

  • In the past year DOX has reported negative net income.
  • In the past year DOX had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: DOX reported negative net income in multiple years.
  • In the past 5 years DOX always reported a positive cash flow from operatings.
DOX.MI Yearly Net Income VS EBIT VS OCF VS FCFDOX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -2.85%, DOX is doing worse than 64.04% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -14.30%, DOX is doing worse than 71.93% of the companies in the same industry.
  • DOX's Return On Invested Capital of 0.75% is in line compared to the rest of the industry. DOX outperforms 47.37% of its industry peers.
Industry RankSector Rank
ROA -2.85%
ROE -14.3%
ROIC 0.75%
ROA(3y)-6.09%
ROA(5y)-1.79%
ROE(3y)-39%
ROE(5y)-17.38%
ROIC(3y)N/A
ROIC(5y)N/A
DOX.MI Yearly ROA, ROE, ROICDOX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 2K 4K 6K

1.3 Margins

  • DOX's Operating Margin of 0.78% is in line compared to the rest of the industry. DOX outperforms 48.25% of its industry peers.
  • DOX's Gross Margin of 73.08% is in line compared to the rest of the industry. DOX outperforms 47.37% of its industry peers.
  • In the last couple of years the Gross Margin of DOX has remained more or less at the same level.
Industry RankSector Rank
OM 0.78%
PM (TTM) N/A
GM 73.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.02%
GM growth 5Y0.72%
DOX.MI Yearly Profit, Operating, Gross MarginsDOX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

1

2. DOX.MI Health Analysis

2.1 Basic Checks

  • DOX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for DOX has been increased compared to 1 year ago.
  • Compared to 5 years ago, DOX has more shares outstanding
  • Compared to 1 year ago, DOX has an improved debt to assets ratio.
DOX.MI Yearly Shares OutstandingDOX.MI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
DOX.MI Yearly Total Debt VS Total AssetsDOX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • DOX has an Altman-Z score of 0.98. This is a bad value and indicates that DOX is not financially healthy and even has some risk of bankruptcy.
  • DOX has a worse Altman-Z score (0.98) than 70.18% of its industry peers.
  • DOX has a debt to FCF ratio of 7.24. This is a slightly negative value and a sign of low solvency as DOX would need 7.24 years to pay back of all of its debts.
  • DOX has a Debt to FCF ratio of 7.24. This is comparable to the rest of the industry: DOX outperforms 42.98% of its industry peers.
  • DOX has a Debt/Equity ratio of 1.02. This is a high value indicating a heavy dependency on external financing.
  • DOX has a worse Debt to Equity ratio (1.02) than 82.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 7.24
Altman-Z 0.98
ROIC/WACC0.09
WACC8.19%
DOX.MI Yearly LT Debt VS Equity VS FCFDOX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

  • DOX has a Current Ratio of 0.59. This is a bad value and indicates that DOX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.59, DOX is doing worse than 90.35% of the companies in the same industry.
  • DOX has a Quick Ratio of 0.59. This is a bad value and indicates that DOX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of DOX (0.59) is worse than 90.35% of its industry peers.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.59
DOX.MI Yearly Current Assets VS Current LiabilitesDOX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

5

3. DOX.MI Growth Analysis

3.1 Past

  • DOX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 75.05%, which is quite impressive.
  • DOX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.81%.
  • DOX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.31% yearly.
EPS 1Y (TTM)75.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%101.62%
Revenue 1Y (TTM)10.81%
Revenue growth 3Y8.28%
Revenue growth 5Y11.31%
Sales Q2Q%20.73%

3.2 Future

  • Based on estimates for the next years, DOX will show a very strong growth in Earnings Per Share. The EPS will grow by 62.70% on average per year.
  • Based on estimates for the next years, DOX will show a quite strong growth in Revenue. The Revenue will grow by 10.40% on average per year.
EPS Next Y105.88%
EPS Next 2Y62.7%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.63%
Revenue Next 2Y10.4%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
DOX.MI Yearly Revenue VS EstimatesDOX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
DOX.MI Yearly EPS VS EstimatesDOX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 -0.4

5

4. DOX.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DOX. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 16.74, the valuation of DOX can be described as correct.
  • Based on the Price/Forward Earnings ratio, DOX is valued a bit cheaper than 73.68% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.84, DOX is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 16.74
DOX.MI Price Earnings VS Forward Price EarningsDOX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DOX is valued a bit cheaper than the industry average as 74.56% of the companies are valued more expensively.
  • DOX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. DOX is cheaper than 74.56% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.67
EV/EBITDA 11.05
DOX.MI Per share dataDOX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

  • DOX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as DOX's earnings are expected to grow with 62.70% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y62.7%
EPS Next 3YN/A

0

5. DOX.MI Dividend Analysis

5.1 Amount

  • DOX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

DOX.MI Fundamentals: All Metrics, Ratios and Statistics

DOXEE SPA

BIT:DOX (3/13/2026, 7:00:00 PM)

3.72

-0.03 (-0.8%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners1.57%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap43.15M
Revenue(TTM)29.07M
Net Income(TTM)-1.22M
Analysts80
Price Target6.65 (78.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 16.74
P/S 1.48
P/FCF 17.67
P/OCF 10.67
P/B 5.06
P/tB N/A
EV/EBITDA 11.05
EPS(TTM)-0.11
EYN/A
EPS(NY)0.22
Fwd EY5.97%
FCF(TTM)0.21
FCFY5.66%
OCF(TTM)0.35
OCFY9.38%
SpS2.51
BVpS0.73
TBVpS-1.76
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.85%
ROE -14.3%
ROCE 1%
ROIC 0.75%
ROICexc 0.83%
ROICexgc N/A
OM 0.78%
PM (TTM) N/A
GM 73.08%
FCFM 8.4%
ROA(3y)-6.09%
ROA(5y)-1.79%
ROE(3y)-39%
ROE(5y)-17.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.02%
GM growth 5Y0.72%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 7.24
Debt/EBITDA 1.64
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.21
Cash Conversion 76.41%
Profit Quality N/A
Current Ratio 0.59
Quick Ratio 0.59
Altman-Z 0.98
F-Score6
WACC8.19%
ROIC/WACC0.09
Cap/Depr(3y)153.21%
Cap/Depr(5y)N/A
Cap/Sales(3y)23.76%
Cap/Sales(5y)22.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)75.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%101.62%
EPS Next Y105.88%
EPS Next 2Y62.7%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)10.81%
Revenue growth 3Y8.28%
Revenue growth 5Y11.31%
Sales Q2Q%20.73%
Revenue Next Year10.63%
Revenue Next 2Y10.4%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y105.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year4354.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y144.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y875.55%
OCF growth 3Y-10.06%
OCF growth 5Y-10.58%

DOXEE SPA / DOX.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DOXEE SPA (DOX.MI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to DOX.MI.


What is the valuation status for DOX stock?

ChartMill assigns a valuation rating of 5 / 10 to DOXEE SPA (DOX.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for DOXEE SPA?

DOXEE SPA (DOX.MI) has a profitability rating of 2 / 10.